Distribution of BCR::ABL1 transcript types and response to therapy in pediatric patients with chronic myeloid leukemia

被引：0
|
作者：
Seiser, E. [1 ]
Behrens, Y. L. [2 ]
Lukat, S. [3 ]
Metzler, M. [3 ]
Krumbholz, M. [3 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nurnberg FAU, Erlangen, Germany
[2] Hannover Med Sch, Hannover, Germany
[3] Univ Hosp Erlangen, Erlangen, Germany
来源：
KLINISCHE PADIATRIE | 2024年 / 236卷 / 03期
关键词：
D O I：
10.1055/s-0044-1786623
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
0072
引用
收藏
页码：214 / 214
页数：1
相关论文
共 50 条
  • [41] The BCR-ABL1 Transcript Type Does Not Influence the Response and the Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Breccia, Massimo
    Stagno, Fabio
    Levato, Luciano
    Fava, Carmen
    Luciano, Luigiana
    Intermesoli, Tamara
    Cedrone, Michele
    Carella, Angelo Michele
    Cavazzini, Francesco
    Turri, Diamante
    Avanzini, Paolo
    Pierri, Ivana
    Lunghi, Monia
    Venturi, Claudia
    Soverini, Simona
    Testoni, Nicoletta
    Alimena, Giuliana
    Saglio, Giuseppe
    Martinelli, Giovanni
    Pane, Fabrizio
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2012, 120 (21)
  • [42] Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia
    Lin, Han-Xin
    Sjaarda, Jenny
    Dyck, Jocob
    Stringer, Randa
    Hillis, Chris
    Harvey, Maria
    Carter, Ronald
    Ainsworth, Peter
    Leber, Brian
    Pare, Guillaume
    Sadikovic, Bekim
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (04) : 360 - 366
  • [43] The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors
    Jabbour, Elias J.
    Sasaki, Koji
    Haddad, Fadi G.
    Issa, Ghayas C.
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    Jain, Nitin
    Yilmaz, Musa
    DiNardo, Courtney D.
    Patel, Keyur P.
    Kanagal-Shamanna, Rashmi
    Champlin, Richard
    Khouri, Issa F.
    Dellasala, Sara
    Pierce, Sherry A.
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : 658 - 665
  • [44] BCR/ABL mRNA types and thrombopoiesis in chronic myeloid leukemia.
    Perego, RA
    Costantini, M
    Cornacchini, G
    Gargantini, L
    Bianchi, C
    Morra, E
    BLOOD, 1998, 92 (10) : 247B - 247B
  • [45] Distribution of BCR::ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival
    Romero-Morelos, Pablo
    Gonzalez-Yebra, Ana Lilia
    Herrerias-Garcia, Anaid
    Ruiz-Velazquez, Francisco Arath
    Bueno-Rosario, Luis Jonathan
    Gonzalez-Yebra, Beatriz
    GENES, 2024, 15 (05)
  • [46] BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR
    Antonella Zagaria
    Luisa Anelli
    Nicoletta Coccaro
    Giuseppina Tota
    Paola Casieri
    Angelo Cellamare
    Luciana Impera
    Claudia Brunetti
    Angela Minervini
    Crescenzio Francesco Minervini
    Mario Delia
    Cosimo Cumbo
    Paola Orsini
    Giorgina Specchia
    Francesco Albano
    Virchows Archiv, 2015, 467 : 357 - 363
  • [47] Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia
    Benjamin Podvin
    Hélène Guermouche
    Pauline Roynard
    Laure Goursaud
    Céline Berthon
    Mahdi Ouafi
    Elise Fourner
    Nicolas Duployez
    Olivier Nibourel
    Catherine Roche-Lestienne
    Annals of Hematology, 2022, 101 : 2093 - 2095
  • [48] Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia
    Podvin, Benjamin
    Guermouche, Helene
    Roynard, Pauline
    Goursaud, Laure
    Berthon, Celine
    Ouafi, Mahdi
    Fourner, Elise
    Duployez, Nicolas
    Nibourel, Olivier
    Roche-Lestienne, Catherine
    ANNALS OF HEMATOLOGY, 2022, 101 (09) : 2093 - 2095
  • [49] Does BCR-ABL transcript type predict cytogenetic response to imatinib mesylate in chronic phase, chronic myeloid leukemia patients?
    Sharma, P.
    Kumar, L.
    Mohanty, S.
    Bose, S.
    Kochupillai, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] RESPONSE TO NILOTINIB IN PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH DIFFERENT BCR-ABL TRANSCRIPT TYPES
    Saglio, S.
    Hughes, T.
    Kim, D. W.
    Hanfstein, B.
    Gottardi, E.
    Branford, S.
    Goh, H.
    Beppu, L.
    Soverini, S.
    Shou, Y.
    Stein, A.
    Woodman, R.
    Kantarjian, H.
    Radich, J.
    Hochhaus, A.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 342 - 343
12345